Open-label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% Cream
Clinical trial NCT00189306 · COMPLETED
Trial details
- NCT number
- NCT00189306
- Sponsor
- Graceway Pharmaceuticals, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-03-01
- Primary completion
- 2007-04-01
- Enrollment
- 169
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.